Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
Fiche publication
Date publication
octobre 2023
Journal
Journal of Crohn's & colitis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume, Pr FEUGIER Pierre, Pr MAYNADIE Marc, Pr BROSEUS Julien, Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Muller M, Broséus J, Guilloteau A, Wasse S, Thiéblemont C, Nancey S, Cadiot G, Amiot A, Laharie D, Vieujean S, Bouhnik Y, Martineau C, Michiels C, Hebuterne X, Savoye G, Franchimont D, Seksik P, Beaugerie L, Maynadié M, Feugier P, Peyrin-Biroulet L
Lien Pubmed
Résumé
IBD is associated with an increased risk of developing lymphoma. Although recent data clarifies lymphoma epidemiology in IBD patients, clinical and pathological characteristics of lymphoma occurring in IBD remain ill-known.
Mots clés
Crohn’s disease, inflammatory bowel disease, lymphoma, prognosis, ulcerative colitis
Référence
J Crohns Colitis. 2023 10 18;: